EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Angiosarcoma: A population-based cancer registry descriptive study of 45 consecutive cases diagnosed between 1979 and 2016

Morgane Colas, Aurélie Gérazime, Dragos Popescu, Eve Puzenat, Loic Chaigneau, Anne Sophie Woronoff, Anne Sophie Dupond, Charlée Nardin, François Aubin iD

Rare Tumors · 2020-01 · 12

DOI: 10.1177/2036361320979216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rare Tumors, online erschienen am 14.12.2020. Verfasst von Morgane Colas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sce de Dermatologie, Inserm 1098 RIGHT, Université de Franche Comté, Centre Hospitalier Universitaire, Besançon, France. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiosarcoma (AS) is a rare aggressive sarcoma with differentiation toward blood or lymphatic endothelium. There are few epidemiological data available on AS. To address this limitation, we investigated the epidemiological and clinical features of angiosarcoma diagnosed in a French administrative area (the Doubs department) from 1979 to 2016. A retrospective cohort study was conducted using the Doubs cancer registry database. A total of 45 patients with invasive AS were diagnosed between 1979 and 2016 in the Doubs department. Among the 45 AS, 51% were either cutaneous AS (27%), including head and neck and extremities, or breast AS (24%) as compared to visceral AS (42%). Eleven patients had metastasis at diagnosis (26%). Age-standardized incidence rate was 0.15 per 100,000 persons-years (95%CI, 0.10–0.20) for the entire study period (1979–2016) and 0.26 (95%CI, 0.15–0.42) for the last decade (2007–2016). Crude survival at 1, 3, 5 years after diagnosis was 44%, 21%, and 12%, respectively. Our population-based study provides updated data on the incidence and overall survival of AS in a French population-based cancer registry.

Schlagwörter

Stichwörter der Autor:innen

angiosarcomaincidencesurvival

Autor:innen und Institutionen

  • Sce de Dermatologie, Inserm 1098 RIGHT, Université de Franche Comté, Centre Hospitalier Universitaire, Besançon, France.
  • Registre des Tumeurs du Doubs, EA3181, Université de Franche Comté, Centre Hospitalier Universitaire, Besançon, France.
  • Sce de Dermatologie, Hôpital Nord Franche Comté, Trévenans, France.
  • Service d'Oncologie Médicale, Centre Hospitalier Universitaire, Besançon, France.

ORCID-Profile: François Aubin

Zitieren

APA

Colas, M., Gérazime, A., Popescu, D., Puzenat, E., Chaigneau, L., Woronoff, A. S., Dupond, A. S., Nardin, C., & Aubin, F. (2020). Angiosarcoma: A population-based cancer registry descriptive study of 45 consecutive cases diagnosed between 1979 and 2016. Rare Tumors, 12. https://doi.org/10.1177/2036361320979216

Vancouver

Colas M, Gérazime A, Popescu D, Puzenat E, Chaigneau L, Woronoff AS, et al. Angiosarcoma: A population-based cancer registry descriptive study of 45 consecutive cases diagnosed between 1979 and 2016. Rare Tumors. 2020;12. doi:10.1177/2036361320979216

BibTeX
@article{Colas2020,
  author = {Colas, Morgane and Gérazime, Aurélie and Popescu, Dragos and Puzenat, Eve and Chaigneau, Loic and Woronoff, Anne Sophie and Dupond, Anne Sophie and Nardin, Charlée and Aubin, François},
  title = {Angiosarcoma: A population-based cancer registry descriptive study of 45 consecutive cases diagnosed between 1979 and 2016},
  journal = {Rare Tumors},
  year = {2020},
  volume = {12},
  doi = {10.1177/2036361320979216}
}
Kostenlos starten →